Latest News

Telix Pharmaceuticals (ASX:TLX) has caught investor attention after confirming it has wrapped up Part 1 of its pivotal ProstACT Phase 3 trial and already started dosing patients in Part 2 globally. See our latest analysis for Telix Pharmaceuticals. Even with this steady clinical and commercial progress, Telix’s 1 month share price return of minus 15.93 percent and year to date share price return of minus 50.42 percent show momentum has cooled. However, the 5 year total shareholder return of...

United Parks & Resorts’ fiscal Q3 2025 results, released earlier this year, fell short of expectations as revenue and earnings were hit by unfavorable calendar shifts, poor holiday weather, and softer international visitation that weighed on park attendance. Despite these headwinds, management highlighted stronger forward booking trends into 2026, particularly at Discovery Cove and in group business, suggesting that advance demand may be more resilient than the recent quarter implied. We’ll...

Xenia Hotels & Resorts, Inc. (XHR) just wrapped up a long running share repurchase program, buying 3.7 million shares since July and bringing total buybacks since 2015 to roughly 28.2 million shares. See our latest analysis for Xenia Hotels & Resorts. The timing is interesting too, with the 1 month share price return of 11.82% and a 1 year total shareholder return of 5% suggesting momentum is starting to rebuild from a relatively modest base. If this buyback has you thinking about where else...

Industrial and Commercial Bank of China (SEHK:1398) is in focus after its ICBC Thai leasing arm deepened cooperation with solar specialist Sungrow, rolling out a new energy financing lease policy to support Thailand’s net zero ambitions. See our latest analysis for Industrial and Commercial Bank of China. Despite the recent pullback, with a 30 day share price return of minus 4.82 percent from HK$6.12, momentum is still broadly constructive given the 26.19 percent year to date share price...

MakeMyTrip (MMYT) recently drew investors’ attention after new analyst coverage with an Outperform rating coincided with a 5% rise in its share price, supported by stronger international air ticketing and hotel revenues. See our latest analysis for MakeMyTrip. That bullish reaction fits into a more mixed year for MakeMyTrip, with a 30 day share price return of 14.31% but a year to date share price return of negative 27.40%. The five year total shareholder return of 210.33% still speaks to...

Recently, Ardagh Metal Packaging S.A. received a favorable Zacks Rank of #2, supported by a 5.9% increase in its full-year consensus earnings estimate over the past three months. This stronger earnings outlook, combined with its outperformance versus Industrial Products sector peers so far this year, highlights rising confidence in Ardagh’s ability to convert sustained demand for metal beverage cans into improved profitability. We’ll now explore how this improved earnings outlook and analyst...

Siemens (XTRA:SIE) has quietly outperformed the wider European industrials group this year, and with the share price up roughly 4 % over the past month, investors are asking what is driving the momentum. See our latest analysis for Siemens. That momentum sits on top of a strong backdrop, with a roughly 23 % year to date share price return and multi year total shareholder returns comfortably ahead of many European peers. This suggests investors are leaning into Siemens digital and automation...

First Citizens BancShares (FCNC.A) has quietly climbed about 17% over the past month, catching investors attention as bank stocks remain choppy. That move invites a closer look at what the market is now pricing in. See our latest analysis for First Citizens BancShares. The latest jump sits on top of a steadier backdrop, with the share price now at $2111.59 and a 90 day share price return of 13.11% that builds on a standout 3 year total shareholder return of 187.59%. This suggests momentum is...

SES AI (SES) just put a spotlight on its roadmap ahead of its 5th annual Battery World, lining up software, capacity, and partnership updates that could reshape how investors think about this battery developer. See our latest analysis for SES AI. The latest roadmap tease comes after a choppy stretch, with a 1 day share price return of minus 7.14 percent and a 7 day share price return of minus 12.50 percent. However, the 1 year total shareholder return of 357.29 percent signals that longer...

Principal Financial Group (PFG) has quietly put together a solid run, with the stock up about 9% over the past month and 15% year to date, outpacing many peers in the financial sector. See our latest analysis for Principal Financial Group. That steady climb to a recent share price of $89.37, backed by a roughly mid-teens year to date share price return and a strong five year total shareholder return, suggests investors are gradually rewarding Principal Financial Group for improving growth and...

At its 2025 TCL Global Technology Innovation Conference held earlier this year, TCL Electronics highlighted broad AI integration across its operations, unveiling the X-Intelligence 3.0 large language model, Inkjet-printed OLED display production, and a suite of AI-enabled consumer devices. A distinctive element of the event was TCL’s emphasis on pairing proprietary AI platforms with sustainability-focused hardware, underpinned by global R&D investment and intelligent factories. We’ll now...

BYD (SEHK:1211) just fired a clear warning shot in Thailand, slashing Seal sedan prices by up to 38% and promising compensation for early buyers if cuts continue. This move is putting volumes, margins and sentiment in sharp focus. See our latest analysis for BYD. Investors have been recalibrating expectations around these aggressive tactics, with the share price now at HK$93.9 and a 90 day share price return of minus 17.27% contrasting with a still solid 3 year total shareholder return of...

Baird’s downgrade of Zimmer Biomet Holdings (ZBH) to Neutral, along with lower targets from other brokers, has cooled near term enthusiasm, even as the company maintains its dividend and advances a new digital health partnership. See our latest analysis for Zimmer Biomet Holdings. Against that backdrop, Zimmer Biomet’s share price near $91.56 reflects a stock where momentum has faded, with a negative year to date share price return and weak multi year total shareholder returns despite solid...

Wynn Resorts and Marjan earlier announced that Wynn Al Marjan Island in Ras Al Khaimah had reached its topping-out milestone, with the US$5.10 billion integrated resort on track for a Spring 2027 opening and set to feature the UAE’s first casino under an exclusive 15-year license. The project is expected to become a major fee and cash-flow contributor for Wynn Resorts, as its 40% equity stake and management and license agreements could meaningfully diversify earnings into a new, high-end...

BJ's Wholesale Club Holdings (BJ) just delivered third quarter earnings that met revenue expectations while topping its own profit guidance, a show of consistency that immediately prompted fresh analyst moves across the stock. See our latest analysis for BJ's Wholesale Club Holdings. The latest report seems to have nudged sentiment back in BJ's favor. The share price is at $95.91 and the 7 day share price return of 7.03% hints that near term momentum is improving. This comes even though the 1...

It looks like Restaurant Brands International Limited Partnership ( TSE:QSP.UN ) is about to go ex-dividend in the next...

Repsol (BME:REP) has quietly pulled ahead of many European energy peers this year, with the stock up about 30% year to date even after a weaker past month and past week. See our latest analysis for Repsol. The recent pullback, including a 1 month share price return of minus 8.77%, looks more like a breather within a strong run. Year to date share price gains and a robust 1 year total shareholder return suggest momentum is still broadly positive. If Repsol’s move has you rethinking your energy...

Healthpeak Properties (DOC) has quietly slid about 12% over the past year and nearly 19% year to date. This has occurred even as annual revenue and net income have both grown, creating an interesting disconnect for income-focused investors. See our latest analysis for Healthpeak Properties. That steady slide in the share price over the past year contrasts with improving fundamentals. This suggests investors are still cautious on healthcare real estate REITs, even as Healthpeak’s cash flows...

KLN Logistics Group (SEHK:636) has quietly outperformed the broader market this year, with the share price edging higher and annual revenue and net income both growing around 3%, drawing fresh interest from value focused investors. See our latest analysis for KLN Logistics Group. Trading at HK$7.07, the stock has staged a modest near term recovery with a 1 month share price return of 2.02%, but its 3 year total shareholder return of negative 38.67% shows longer term momentum is still...

NetScout Systems (NTCT) just turned heads with second quarter fiscal 2026 earnings that topped Wall Street on both revenue and EPS, a clear signal that operations and investor confidence are moving in the right direction. See our latest analysis for NetScout Systems. The strong quarterly beat comes after a steady recovery, with a roughly 26 percent year to date share price return and 25 percent one year total shareholder return suggesting momentum is rebuilding despite weaker three year and...

Match Group (MTCH) just shuffled its leadership deck by bringing former CEO Spencer Rascoff onto the board and elevating Hinge founder Justin McLeod to chairman, a move investors are weighing against recent stock underperformance. See our latest analysis for Match Group. Those leadership moves land at an inflection point, with Match’s 1 year total shareholder return of 5.17% masking a softer 90 day share price return of minus 15.58%, suggesting fading near term momentum despite longer term...

Celestica Inc. recently announced that Dr. Luis Müller will resign from its Board and as Audit Committee Chair after the January 28, 2026 meeting, with current director Amar Maletira set to assume the audit leadership role given his extensive public-company finance experience. The orderly succession from Dr. Müller to Mr. Maletira underscores Celestica’s emphasis on maintaining strong financial oversight just as investors focus on its AI and data center exposure. We’ll now examine how this...

Earlier this week, Baker Hughes announced a major multi-year award from Kuwait Oil Company to supply advanced artificial lift systems, including electrical submersible pumps, plus installation, surveillance and maintenance services for Kuwait’s oil and gas fields. The deal highlights how Baker Hughes is pairing hardware with its FusionPro intelligent production drive and Leucipa automated field production solution to deepen its role in long-term, technology-driven production optimization for...

RemeGen (SEHK:9995) has just been added to the Shanghai Stock Exchange Health Care Sector Index, a change that puts the biotech directly on the radar of sector trackers and index-linked funds. See our latest analysis for RemeGen. The latest index inclusion comes after a sharp run, with the year to date share price return of 468.99% and a 396.12% one year total shareholder return now giving way to softer short term momentum as traders reassess risk and future growth. If RemeGen’s surge has you...